TPIDB > 臨床試驗主持人
臨床試驗主持人
更新時間：2023-09-19
倪衍玄NI, YEN-HSUAN
- 計畫主持人
- 執行臨床試驗年資 17 年 9 個月
發表文獻
31筆
1
Chiang CM, Hsu WM, Chang MH, Hsu HY, Ni YH, Chen HL, Wu JF. Risk factors and management for anastomotic stricture after surgical reconstruction of esophageal atresia. J Formos Med Assoc. 2021 Jan;120(1 Pt 2):404-410. doi: 10.1016/j.jfma.2020.06.020. Epub 2020 Jun 22. PMID: 32586720.
2
Hsu HY, Chen HL, Wu JF, Ni YH, Chang KC, Chiang CL, Lee CN, Zhao LL, Lai MW, Mu SC, Wen WH, Lin LH, Chang MH; Taiwan Study Group for the Prevention of Mother-to-Infant Transmission of HBV (PreMIT study). Occult Hepatitis B Virus Infection in Immunized Infants Born to Untreated and Tenofovir-Treated Highly Viremic Mothers. Clin Gastroenterol Hepatol. 2021 Jul;19(7):1494-1496. doi: 10.1016/j.cgh.2020.07.041. Epub 2020 Jul 23. PMID: 32712392.
3
Wu SH, Chang MH, Chen YH, Wu HL, Chua HH, Chien CS, Ni YH, Chen HL, Chen HL. The ESCRT-III molecules regulate the apical targeting of bile salt export pump. J Biomed Sci. 2021 Mar 9;28(1):19. doi: 10.1186/s12929-020-00706-2. PMID: 33750401; PMCID: PMC7941988.
4
Wu JF, Chang KC, Ni YH, Hsu HY, Chang MH. Impacts of the Percentage of Basal Core Promoter Mutation on the Progression of Liver Fibrosis After Hepatitis B e Antigen Seroconversion. J Infect Dis. 2021 Apr 23;223(8):1381-1389. doi: 10.1093/infdis/jiaa545. PMID: 32860707.
5
Lin YC, Chang PF, Liu K, Chang MH, Ni YH. Predictors for incidence and remission of nonalcoholic fatty liver disease in obese children and adolescents. J Formos Med Assoc. 2022 Jan;121(1 Pt 1):36-42. doi: 10.1016/j.jfma.2021.01.004. Epub 2021 Jan 24. PMID: 33504463.
6
Lee BC, Hsieh ST, Chang YL, Tseng FY, Lin YJ, Chen YL, Wang SH, Chang YF, Ho YL, Ni YH, Chang SC. A Web-Based Virtual Microscopy Platform for Improving Academic Performance in Histology and Pathology Laboratory Courses: A Pilot Study. Anat Sci Educ. 2020 Nov;13(6):743-758. doi: 10.1002/ase.1940. Epub 2020 Jan 27. PMID: 31883209.
7
Indolfi G, Fischler B, Gonzalez-Peralta RP, Ciocca M, Porta G, Neelam M, El-Guindi M, Kelly D, Ni YH, Sibal A, Leung DH, Chang MH; Hepatitis Expert Team of the Federation of International Societies of Pediatric Gastroenterology, Hepatology, and Nutrition (FISPGHAN). Comparison of Recommendations for Treatment of Chronic Hepatitis C Virus Infection in Children and Adolescents: A Position Paper of the Federation of International Societies of Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2020 May;70(5):711-717. doi: 10.1097/MPG.0000000000002710. PMID: 32205770.
8
Wu JF, Ho MC, Ni YH, Hsu HY, Lee PH, Chang MH. Dysregulation of liver developmental microRNA contribute to hepatic carcinogenesis. J Formos Med Assoc. 2020 Jun;119(6):1041-1051. doi: 10.1016/j.jfma.2019.09.018. Epub 2019 Oct 15. PMID: 31627983.
9
Hsu WY, Chang HH, Lu MY, Yang YL, Jou ST, Chen HL, Ni YH, Hsu HY, Chang MH, Wu JF. Clinical risk stratification of children with SIOPEL high-risk hepatoblastoma in Taiwan. Pediatr Neonatol. 2020 Aug;61(4):393-398. doi: 10.1016/j.pedneo.2020.03.012. Epub 2020 Mar 24. PMID: 32291200.
10
Lin YC, Wu CC, Ni YH. New Perspectives on Genetic Prediction for Pediatric Metabolic Associated Fatty Liver Disease. Front Pediatr. 2020 Dec 9;8:603654. doi: 10.3389/fped.2020.603654. PMID: 33363067; PMCID: PMC7755886.
